Abstract
AbstractThe mortality associated with HIV has declined since the introduction of combination antiretroviral therapy (cART) and life expectancy for those who begin treatment early enough is now approaching that of the general population. However, key concerns in maintaining long‐term control of HIV are side‐effects and convenience/adherence. This review will discuss the available and recently introduced treatments, and the potential future therapies currently under investigation.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
